219 related articles for article (PubMed ID: 28444500)
1. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.
Glomski K; Nosé V; Faquin WC; Sadow PM
Endocr Pathol; 2017 Jun; 28(2):177-185. PubMed ID: 28444500
[TBL] [Abstract][Full Text] [Related]
2. Evolution of the histologic classification of thyroid neoplasms and its impact on clinical management.
Xu B; Ghossein R
Eur J Surg Oncol; 2018 Mar; 44(3):338-347. PubMed ID: 28554832
[TBL] [Abstract][Full Text] [Related]
3. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
[TBL] [Abstract][Full Text] [Related]
4. Follicular and Hürthle cell lesions of the thyroid: can inconclusive results be minimized?
Sherman JF; Leiman G; Naud S; Nathan MH; Ambaye AB
Acta Cytol; 2008; 52(6):659-64. PubMed ID: 19068668
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
Ghuzlan AA; Ramos HE; Schlumberger M
Curr Opin Endocrinol Diabetes Obes; 2017 Oct; 24(5):377-380. PubMed ID: 28678083
[TBL] [Abstract][Full Text] [Related]
6. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
[TBL] [Abstract][Full Text] [Related]
7. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
Gemsenjäger E; Heitz PU; Martina B; Schweizer I
Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
[TBL] [Abstract][Full Text] [Related]
8. Modified Transverse-Vertical Gross Examination: a Better Method for the Detection of Definite Capsular Invasion in Encapsulated Follicular-Patterned Thyroid Neoplasms.
Oh HS; Kim SJ; Song E; Lee YM; Sung TY; Kim WG; Kim TY; Song DE
Endocr Pathol; 2019 Jun; 30(2):106-112. PubMed ID: 30661168
[TBL] [Abstract][Full Text] [Related]
9. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
[TBL] [Abstract][Full Text] [Related]
10. Hybrid thyroid carcinoma with a coarse chromatin pattern and nuclear features of papillary thyroid carcinoma.
Mai KT; Bokhary R; Yazdi HM; Thomas J
Pathol Res Pract; 2002; 198(4):253-60. PubMed ID: 12049333
[TBL] [Abstract][Full Text] [Related]
11. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
12. Follicular thyroid neoplasm: clinicopathologic features suggesting malignancy.
Heikkilä A; Siironen P; Hagström J; Heiskanen I; Sankila R; Louhimo J; Haglund C; Arola J
APMIS; 2010 Nov; 118(11):846-54. PubMed ID: 20955457
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
[TBL] [Abstract][Full Text] [Related]
14. Invasion rather than nuclear features correlates with outcome in encapsulated follicular tumors: further evidence for the reclassification of the encapsulated papillary thyroid carcinoma follicular variant.
Ganly I; Wang L; Tuttle RM; Katabi N; Ceballos GA; Harach HR; Ghossein R
Hum Pathol; 2015 May; 46(5):657-64. PubMed ID: 25721865
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
Covach A; Patel S; Hardin H; Lloyd RV
Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.
Ghossein RA; Hiltzik DH; Carlson DL; Patel S; Shaha A; Shah JP; Tuttle RM; Singh B
Cancer; 2006 Apr; 106(8):1669-76. PubMed ID: 16534796
[TBL] [Abstract][Full Text] [Related]
17. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
Roth LM; Miller AW; Talerman A
Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
[TBL] [Abstract][Full Text] [Related]
18. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas.
Furlan JC; Bedard YC; Rosen IB
J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733
[TBL] [Abstract][Full Text] [Related]
20. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
